Literature DB >> 24307582

Interactions between herpesvirus entry mediator (TNFRSF14) and latency-associated transcript during herpes simplex virus 1 latency.

Sariah J Allen1, Antje Rhode-Kurnow, Kevin R Mott, Xianzhi Jiang, Dale Carpenter, J Ignacio Rodriguez-Barbosa, Clinton Jones, Steven L Wechsler, Carl F Ware, Homayon Ghiasi.   

Abstract

Herpesvirus entry mediator (HVEM) is one of several cell surface proteins herpes simplex virus (HSV) uses for attachment/entry. HVEM regulates cellular immune responses and can also increase cell survival. Interestingly, latency-associated transcript (LAT), the only viral gene consistently expressed during neuronal latency, enhances latency and reactivation by promoting cell survival and by helping the virus evade the host immune response. However, the mechanisms of these LAT activities are not well understood. We show here for the first time that one mechanism by which LAT enhances latency and reactivation appears to be by upregulating HVEM expression. HSV-1 latency/reactivation was significantly reduced in Hvem(-/-) mice, indicating that HVEM plays a significant role in HSV-1 latency/reactivation. Furthermore, LAT upregulated HVEM expression during latency in vivo and also when expressed in vitro in the absence of other viral factors. This study suggests a mechanism whereby LAT upregulates HVEM expression potentially through binding of two LAT small noncoding RNAs to the HVEM promoter and that the increased HVEM then leads to downregulation of immune responses in the latent microenvironment and increased survival of latently infected cells. Thus, one of the mechanisms by which LAT enhances latency/reactivation appears to be through increasing expression of HVEM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24307582      PMCID: PMC3911542          DOI: 10.1128/JVI.02467-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

Review 1.  Human herpesviruses: a consideration of the latent state.

Authors:  J G Stevens
Journal:  Microbiol Rev       Date:  1989-09

Review 2.  IAP proteins: regulators of cell migration and development.

Authors:  Niall S Kenneth; Colin S Duckett
Journal:  Curr Opin Cell Biol       Date:  2012-12-05       Impact factor: 8.382

3.  A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia.

Authors:  I Steiner; J G Spivack; S L Deshmane; C I Ace; C M Preston; N W Fraser
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Herpes simplex virus latent phase transcription facilitates in vivo reactivation.

Authors:  J M Hill; F Sedarati; R T Javier; E K Wagner; J G Stevens
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

5.  Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans.

Authors:  S L Wechsler; A B Nesburn; R Watson; S Slanina; H Ghiasi
Journal:  J Gen Virol       Date:  1988-12       Impact factor: 3.891

6.  The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection.

Authors:  E K Wagner; W M Flanagan; G Devi-Rao; Y F Zhang; J M Hill; K P Anderson; J G Stevens
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency.

Authors:  D A Leib; C L Bogard; M Kosz-Vnenchak; K A Hicks; D M Coen; D M Knipe; P A Schaffer
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

8.  The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency.

Authors:  G C Perng; E C Dunkel; P A Geary; S M Slanina; H Ghiasi; R Kaiwar; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia.

Authors:  N M Sawtell; R L Thompson
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Small non-coding RNAs encoded within the herpes simplex virus type 1 latency associated transcript (LAT) cooperate with the retinoic acid inducible gene I (RIG-I) to induce beta-interferon promoter activity and promote cell survival.

Authors:  Leticia Frizzo da Silva; Clinton Jones
Journal:  Virus Res       Date:  2013-05-03       Impact factor: 3.303

View more
  25 in total

Review 1.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  A herpes simplex virus type 1 mutant disrupted for microRNA H2 with increased neurovirulence and rate of reactivation.

Authors:  Xianzhi Jiang; Don Brown; Nelson Osorio; Chinhui Hsiang; Lily Li; Lucas Chan; Lbachir BenMohamed; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-02-03       Impact factor: 2.643

3.  Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.

Authors:  Lbachir BenMohamed; Nelson Osorio; Ruchi Srivastava; Arif A Khan; Jennifer L Simpson; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-05-22       Impact factor: 2.643

4.  Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2.

Authors:  Xianzhi Jiang; Don Brown; Nelson Osorio; Chinhui Hsiang; Lbachir BenMohamed; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-06-12       Impact factor: 2.643

5.  The Absence of Lymphotoxin-α, a Herpesvirus Entry Mediator (HVEM) Ligand, Affects Herpes Simplex Virus 1 Infection In Vivo Differently than the Absence of Other HVEM Cellular Ligands.

Authors:  Shaohui Wang; Satoshi Hirose; Homayon Ghiasi
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

6.  Roles of M1 and M2 Macrophages in Herpes Simplex Virus 1 Infectivity.

Authors:  Dhong Hyun Lee; Homayon Ghiasi
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

7.  An M2 Rather than a TH2 Response Contributes to Better Protection against Latency Reactivation following Ocular Infection of Naive Mice with a Recombinant Herpes Simplex Virus 1 Expressing Murine Interleukin-4.

Authors:  Dhong Hyun Lee; Homayon Ghiasi
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

8.  Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.

Authors:  Shaohui Wang; Alexander V Ljubimov; Ling Jin; Klaus Pfeffer; Mitchell Kronenberg; Homayon Ghiasi
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

Review 9.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  Cell entry mechanisms of HSV: what we have learned in recent years.

Authors:  Alex M Agelidis; Deepak Shukla
Journal:  Future Virol       Date:  2015-10-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.